Hank F.

Scientific Advisor
Scientific Advisory Board
Avid Radiopharmaceuticals
Montenegro

Business Expert Neurology
Biography

Hank F. Kung Ph.D., serves as the Chief Scientific Advisor and Chairman of the Scientific Advisory Board of Avid Radiopharmaceuticals, Inc. Dr. Kung is regarded as a world leader in research and development of innovative radiopharmaceuticals for diagnosis of brain diseases including Alzheimer's disease and Parkinson's disease. Dr. Kung is the inventor of the radiopharmaceuticals IBZM marketed in Europe and Trodat in clinical development in the U.S. for Parkinson's disease. 

Research Intrest

brain diseases like Alzheimer's disease and Parkinson's disease